News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,650 Results
Type
Article (42138)
Company Profile (290)
Press Release (681216)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (205858)
Career Advice (2027)
Deals (35653)
Drug Delivery (105)
Drug Development (81617)
Employer Resources (174)
FDA (16412)
Job Trends (14990)
News (347958)
Policy (32833)
Tag
Academia (2616)
Accelerated approval (27)
Adcomms (24)
Allergies (124)
Alliances (50188)
ALS (163)
Alzheimer's disease (1629)
Antibody-drug conjugate (ADC) (274)
Approvals (16632)
Artificial intelligence (463)
Autoimmune disease (120)
Automation (33)
Bankruptcy (363)
Best Places to Work (11690)
BIOSECURE Act (21)
Biosimilars (178)
Biotechnology (192)
Bladder cancer (147)
Brain cancer (54)
Breast cancer (600)
Cancer (4480)
Cardiovascular disease (365)
Career advice (1709)
Career pathing (34)
CAR-T (265)
CDC (44)
Celiac Disease (1)
Cell therapy (692)
Cervical cancer (35)
Clinical research (69276)
Collaboration (1494)
Company closure (4)
Compensation (1065)
Complete response letters (46)
COVID-19 (2718)
CRISPR (84)
C-suite (700)
Cystic fibrosis (136)
Data (5771)
Decentralized trials (2)
Denatured (25)
Depression (112)
Diabetes (464)
Diagnostics (6695)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (224)
Drug pricing (167)
Drug shortages (29)
Duchenne muscular dystrophy (212)
Earnings (89904)
Editorial (51)
Employer branding (21)
Employer resources (152)
Events (117369)
Executive appointments (943)
FDA (19221)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1340)
Gene editing (189)
Generative AI (40)
Gene therapy (549)
GLP-1 (924)
Government (4654)
Grass and pollen (6)
Guidances (376)
Healthcare (18954)
HIV (49)
Huntington's disease (39)
IgA nephropathy (75)
Immunology and inflammation (231)
Immuno-oncology (39)
Indications (78)
Infectious disease (2962)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (104)
Intellectual property (217)
Interviews (315)
IPO (16681)
IRA (48)
Job creations (3658)
Job search strategy (1435)
Kidney cancer (15)
Labor market (79)
Layoffs (544)
Leadership (29)
Legal (7964)
Liver cancer (89)
Longevity (12)
Lung cancer (618)
Lymphoma (356)
Machine learning (38)
Management (59)
Manufacturing (690)
MASH (154)
Medical device (13770)
Medtech (13808)
Mergers & acquisitions (19952)
Metabolic disorders (1156)
Multiple sclerosis (143)
NASH (16)
Neurodegenerative disease (281)
Neuropsychiatric disorders (70)
Neuroscience (2733)
NextGen: Class of 2025 (6567)
Non-profit (4523)
Now hiring (61)
Obesity (534)
Opinion (253)
Ovarian cancer (152)
Pain (176)
Pancreatic cancer (201)
Parkinson's disease (257)
Partnered (31)
Patents (451)
Patient recruitment (411)
Peanut (54)
People (58967)
Pharmaceutical (65)
Pharmacy benefit managers (26)
Phase I (21625)
Phase II (30475)
Phase III (22722)
Pipeline (3963)
Policy (263)
Postmarket research (2570)
Preclinical (9241)
Press Release (69)
Prostate cancer (218)
Psychedelics (43)
Radiopharmaceuticals (271)
Rare diseases (727)
Real estate (5988)
Recruiting (69)
Regulatory (24114)
Reports (51)
Research institute (2435)
Resumes & cover letters (351)
Rett syndrome (23)
RNA editing (12)
RSV (73)
Schizophrenia (139)
Series A (223)
Series B (168)
Service/supplier (11)
Sickle cell disease (95)
Special edition (20)
Spinal muscular atrophy (154)
Sponsored (41)
Startups (3658)
State (2)
Stomach cancer (16)
Supply chain (100)
Tariffs (80)
The Weekly (49)
Vaccines (955)
Venture capital (77)
Weight loss (347)
Women's health (74)
Worklife (17)
Date
Today (74)
Last 7 days (484)
Last 30 days (2249)
Last 365 days (30347)
2025 (30237)
2024 (35442)
2023 (40298)
2022 (51419)
2021 (55953)
2020 (54320)
2019 (46798)
2018 (35230)
2017 (32402)
2016 (31828)
2015 (37856)
2014 (31575)
2013 (26638)
2012 (28839)
2011 (29499)
2010 (27591)
Location
Africa (747)
Alabama (77)
Alaska (7)
Arizona (291)
Arkansas (13)
Asia (39513)
Australia (6453)
California (10527)
Canada (3107)
China (989)
Colorado (438)
Connecticut (455)
Delaware (312)
Europe (85217)
Florida (1550)
Georgia (334)
Hawaii (2)
Idaho (61)
Illinois (793)
India (54)
Indiana (496)
Iowa (21)
Japan (382)
Kansas (123)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1325)
Massachusetts (7622)
Michigan (303)
Minnesota (593)
Mississippi (5)
Missouri (122)
Montana (31)
Nebraska (27)
Nevada (112)
New Hampshire (74)
New Jersey (2830)
New Mexico (28)
New York (2799)
North Carolina (1370)
North Dakota (10)
Northern California (5055)
Ohio (311)
Oklahoma (20)
Oregon (38)
Pennsylvania (2147)
Puerto Rico (19)
Rhode Island (45)
South America (1108)
South Carolina (59)
South Dakota (1)
Southern California (4069)
Tennessee (165)
Texas (1624)
United States (37606)
Utah (311)
Vermont (1)
Virginia (240)
Washington D.C. (78)
Washington State (860)
West Virginia (4)
Wisconsin (91)
Wyoming (2)
723,650 Results for "synthetic genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
December 19, 2025
·
7 min read
Press Releases
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 18, 2025
·
6 min read
Press Releases
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
September 17, 2025
·
7 min read
Press Releases
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
December 18, 2025
·
14 min read
Press Releases
Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open
November 18, 2025
·
6 min read
Press Releases
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
December 3, 2025
·
4 min read
Press Releases
Twist Bioscience Collaborates with Synthetic Design Lab
September 3, 2025
·
5 min read
Press Releases
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale
December 22, 2025
·
3 min read
Press Releases
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting
December 11, 2025
·
6 min read
Press Releases
Moss Genomics Announces Closing of Financing Round
November 13, 2025
·
4 min read
1 of 72,365
Next
